Subsequently, in 2022, the same group published an extensive exhaustive score, named the PedPne score, and expanded the utility across a larger cohort of 321 screened patients with 81 confirmed cases of pneumonia, demonstrating its consistent application over the disease course with strong correlations noted between the US score and CRP, procalcitonin, and leukocyte counts across multiple evaluations [20]. This evidence concerns the gene CRP and susceptibility to pneumonia measurement.